Navigation Links
Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas
Date:2/7/2008

U.S. and three international Affiliates will hear from Ambassador Brinker, the woman who started the global breast cancer movement, and Komen president and CEO, Hala Moddelmog. Attendees will also hear from Komen's chief operating officer, Kimberly Simpson, on the direction of the organization and its Affiliate Network, and Komen chief scientific advisor, Dr. Eric. P. Winer, also a Dana Farber clinician and Harvard professor, on Komen's research strategy. In addition to Komen leadership, conference-goers will receive tips from fundraising guru Dr. Doug Lawson of Lawson Associates, Inc., and motivation from nationally renowned broadcast journalist Susan Stamberg, a special correspondent for NPR.

One new element at Komen's conference this year is the Public Policy Forum, occurring during the pre-conference activities on Thursday. In this all-day forum, Affiliate and national Advisory Council representatives will learn about the expanding role of Komen's advocacy work under the Susan G. Komen for the Cure Advocacy Alliance, the organization's new 501(c)(4) entity. Throughout the past year, Komen advocates across the country have worked tirelessly to increase government investment in vital programs that will close the gaps in research and access to breast health services that prevent people from getting the care they need.

Throughout the weekend, Komen for the Cure will present a number of awards, each bestowed annually, to recognize the extraordinary efforts of Komen advocates who selflessly commit their lives to serving those affected by breast cancer. Honors include the Komen Outstanding Volunteer Awards, Komen Community Service Awards, Jill Ireland Awards for Volunteerism, the Komen Local Television Media Award, the Komen Co-Survivor Award, the 13th annual Komen Affiliate of the Year Award, as well as numerous awards recognizing the critical role of corporate partner programs in furthering Komen's promise.

In addition, Ambassador Brinker will pr
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board
2. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
3. Susan G. Komen for the Cure, State Lawmakers, Breast Cancer Survivors, Celebrities and Activists Call on Legislature to Strengthen Breast Cancer Screening Program for Underserved Women
4. Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer
5. California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services
6. Susan G. Komen for the Cures CEO Hala Moddelmog Earns High Heels in High Places Recognition at 2008 Trumpet Awards
7. Susan G. Komen for the Cures Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer
8. Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs
9. Former NFL Star Tiki Barber and CURE Founder Susan Axelrod Speak Out About Epilepsy on TODAY Show
10. Susan G. Komen for the Cure Names Tim Doke Chief Marketing Officer
11. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... -- Klafter & Olsen LLP has filed a,class action l..." or the,"Company") (Nasdaq: ARTC ) and certain o...Western District of Texas on behalf of all persons...Care from January 24, 2008,through July 18, 2008 (...,persons or entities who purchased call options or...
(Date:7/25/2008)...etroviral therapy may be due to genetic factors ,...new study challenges the long-held belief that the...,s ability to restore itself after HIV patients ar...y (HAART). , From 50 percent to 90 percent of H... Intravenous drug use is the main cause of both ty...
(Date:7/25/2008)...BeaconEquity.com announces the,availability of Tra... can view all of the daily trading notes for free ... Trade Alerts include: DUSA Pharmaceuticals Inc. (...(Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Ado...q: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., Joi...
(Date:7/25/2008)...ificant Improvements in Members, Health, ATLANTA,... in health,care quality management solutions for h...entered into a long-term agreement with Wellmark, ...on on Quality(SM) Incent and,Reward Best Practices...primary care clinicians to promote improved qualit...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
... so-called first world seems to be catching up fas...ity rates or sewage connection.// Only last fortn...t city in Ireland was reeling under a major water ...because of water contamination. Now the news come...
...ures from Canadian experts show that the country w...unless drastic measures are taken. Statistics Cana... heavily on immigration to plug the gaps left in, ...r legs. Says Statistics Canada: β€œAn aging workfo...
...ng wire-free or Wi -Fi is fast becoming a more tha...needs of wires or the need to be connected to a so...ll primary schools and four fifths of all secondar...ere has been the rising of dissenting voices. Teac...
...tors in New York have achieved a major breakthroug...ladder through her vagina. // This technique, they...sual operation, and allow a quicker recovery. The ...d to cut through abdominal muscles, a major source...
Other Medicine News:Health News:Sewage Swamps River in Scotland 2Health News:Statisticians Alarmed As Canada Zooms Towards Labour Shortage 2Health News:Wire-Free – Handcuffing Good Healt 2Health News:New York Doctors Remove Gallbladder Through Vagina 2Health News:New York Doctors Remove Gallbladder Through Vagina 3
(Date:7/22/2008)...ility and Efficacy of Treating Patients with ...NCISCO, and YONGIN-SI, South Korea, July 22 /PRNew...tawa, Ontario), and its South,Korean partner Green...from,a Phase I clinical trial of its first-in-clas...t was well-tolerated and resulted in clear,anti-ca...
(Date:7/22/2008)...tress the Importance to Patients of Passing a ... RICHMOND, Va., July 22 /-...ow-on biologics and biopharmaceuticals, today,anno...ill present at a,Congressional briefing on Friday,...or establishing an approval pathway for follow-on,...
(Date:7/22/2008)... by Columbia University Medical Center Based on ...hnology, The Test Differentiates Squamous From N...lassifying Squamous-Cell Carcinoma of the Lung Wit... of 90 Percent,This is the First CLIA Approved Tes...as Biomarkers for Accurate Diagnosis of Lung Cance...
(Date:7/22/2008)...idual,s Genetic Risk Based on Clinical Data, Pr...al Materials, WALTHAM, Mass., July 22 /PRNewswire...ILI ), today announced the launch of an enhanced t...company,s Heart Health Genetic Test.,The test is c...Heart Health,Genetic Test by Quixtar/Amway. The ne...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Researchers successfully simulate photosynthesis and design a better leaf 1169 1Researchers successfully simulate photosynthesis and design a better leaf 1169 2Researchers successfully simulate photosynthesis and design a better leaf 1169 3Abnormal immune cells may cause unprovoked anaphylaxis 5990 1Abnormal immune cells may cause unprovoked anaphylaxis 5990 2Abnormal immune cells may cause unprovoked anaphylaxis 5990 3Research highlights important indicators of early stage ovarian cancer 5988 1New technology illuminates protein interactions in living cells 1167 1New technology illuminates protein interactions in living cells 1167 2
...ion Therapeutics,announced today that data on two ...prednate) and ST-602 (fenretinide), will be,presen...for,Research in Vision and Ophthalmology (ARVO) in...tions, the company will be hosting a,reception for...ntly being evaluated in two phase,III clinical tri...
...erlying Cause of,Genetic Disorders and Restores Pr...2007 /PRNewswire/ -- New,preclinical data publishe...ure show that PTC124, an investigational new drug,...ious in a,preclinical model of Duchenne muscular d... 13 percent of the cases of DMD are due,to nonsens...
Other Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 2Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 3Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available.
Medicine Products: